• Home
• News
• About Us
• Contact

Search

Tag Cloud

anthrax Strategic National Stockpile Training exercise Bioterror Biomagnetics National Research Council Homeland Security Biodefense lab Army Medical Research Institute antibiotics Emergency preparedness research Bioweapons NIAID smallpox Detection technology CDC TSA Defense Dept IAEM FEMA immunization Ebola Ricin Hendra Plague treaty West Nile Camouflage Paint Marburg antidote weapons destruction Sarin VHF viruses chemical disposal dna technology prevention Robotics Technology research grants tularemia weapons control foot and mouth disease decontamination E. coli Iraq missile defense Bio-Rescue Dengue fever Botulinum toxin antiviral molecular diagnostics Infectious disease

Subscribe to our newsletter

RSS Feed

SLU seeks 250 people for smallpox study
by Nick Rees on February 5, 2010

As part of its recently announced project to create a smallpox vaccine to fight bioterrorism, Saint Louis University has begun seeking 250 volunteers to inject with smallpox.

Study begins to find more effective manner of fighting smallpox
by Ted Purlain on February 3, 2010

A more effective manner of administering an investigational vaccine for smallpox will be studied by scientists at Saint Louis University's Center for Vaccine Development in a study funded by the National Institute of Health.

SIGA Technologies takes part in Israel's simulated bioattack
by Ted Purlain on January 21, 2010

Representatives from SIGA Technologies took part in Israel's recent "Operation Orange Flame 4" biological defense drill conducted by the Defense Ministry and Health Ministry in conjunction with the Israel Defense Forces Home Front Command.

- NIH grants to aid study of smallpox
by Rita Uplend on January 5, 2010

New grants from the U.S. National Institutes of Health will aid in immunological research on several diseases, including smallpox, which could be used by bioterrorists.

Researchers discover how smallpox kills
by Nick Rees on December 24, 2009

While smallpox has been eradicated from the planet as a naturally occurring virus, it still remains a high level biothreat.

Smallpox vaccine adds to potential biodefense stockpile
by Nick Rees on December 2, 2009

Bavarian Nordic A/S, focusing on biodefense, has announced that it expects to file a new drug submission for Imvamune, its third-generation smallpox vaccine.

Major smallpox vaccine order announcement expected
by Paul Tinder on November 27, 2009

The biodefense company SIGA Technologies, which engages in the discovery, development and commercialization of products for use in defense against biological warfare agents, is expected to make a major announcement.

Nanotherapeutics receives contract to develop smallpox drug
by Mary J. Lewis on October 29, 2009

ALACHUA, Fla. — Nanotherapeutics Inc. has been awarded a $30.9 million, five-year contract from the National Institute of Allergy and Infectious Diseases to develop an inhaled version of the injectable antiviral drug, cidofovir, for non-invasive, post-exp

ISBI Conference on de novo Synthesis of Smallpox, Washington DC
by Barry Kellman on July 1, 2009

The communities of experts and officials who focus on bioviolence (the intentional infliction of disease) have long considered smallpox (variola major) to be among the most terrifying bio-agents.